Loading…
Tuesday, June 26 • 4:15pm - 5:30pm
#276: Patient Engagement in Pharmacovigilance

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
Component Type: Session
Level: Advanced
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-604-L04-P; CME 1.25; IACET 1.25; RN 1.25

This session will present current research and emerging best practices in the field of patient risk communication, including methods for collecting patient input in the design of these communication materials.

Learning Objectives

Identify key elements that are needed to make patient educational materials understandable and actionable for patients in their decision-making process regarding treatment; Examine the value of patient-generated real-world safety data, public hearings, and patient input into the development of risk communication tools.

Chair

Deborah E. Collyar

Speaker

Patient Engagement and Pharmacovigilance: Risk Interventions and Strategic Communications (RISC)
Emily Freeman, PhD, MSc

How Will EU Public Hearings Help with Patient and Public Engagement and How Should the Industry Prepare?
Shelley Gandhi, MS

Can Patient-Generated Real-World Data Illuminate Real World Evidence of Safety Concerns Sooner Than Traditional Sources?
David Blaser, PharmD

How Well Are We Doing Conveying Drug Safety Information to Patients? An Analysis of the Quality of REMS Educational Materials
Meredith Y. Smith


Speakers
avatar for David Blaser

David Blaser

Director, Health Informatics, PatientsLikeMe
David Blaser, PharmD is the Director of Health Informatics at PatientsLikeMe. David received his PharmD from Northeastern University and completed a post-doctoral fellowship in health outcomes/pharmacoeconomics at UMass Medical School. He joined PatientsLikeMe in 2011 and now serves... Read More →
avatar for Deborah Collyar

Deborah Collyar

President, Patient Advocates In Research (PAIR)
Deborah Collyar has applied a wealth of leadership skills from her successful IT business career to help create patient-centered medical research and healthcare, after her first cancer diagnosis at the age of 32. She founded Patient Advocates In Research (PAIR) in 1996, “where research... Read More →
avatar for Emily Freeman

Emily Freeman

Director, Patient Centered Outcomes, AbbVie, Inc.
Dr. Emily Freeman is a social/behavioral scientist interested in the development of evidence based communication tools to facilitate decision making between patients and healthcare providers. Dr. Freeman is exploring how medical evidence (i.e. risk, benefit, and health outcomes) is... Read More →
avatar for Shelley Gandhi

Shelley Gandhi

Strategic Advisor, NDA Group
Shelley is an experienced and highly motivated pharmacovigilance and risk management expert, with an international reputation in her field, specialising in delivering global safety solutions including safety governance models. Former senior manager at MHRA for over 19 years and represented... Read More →
avatar for Meredith Smith

Meredith Smith

Global Risk Management Officer, Global Patient Safety, Amgen Inc.
Meredith Smith is Global Risk Management Officer at Amgen, Inc. where she leads a team of 6 scientists responsible for medicinal product benefit-risk assessment and risk management. She is a behavioral scientist and health services researcher by training with over 15 years of experience... Read More →

Tuesday June 26, 2018 4:15pm - 5:30pm
Room 253AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  01: ClinSafety-PV, Session